Johnson & Johnson (JNJ) on Wallstrip...Long Overdue

Consumer

The Consumer segment includes a range of products used in the baby and kids care, skin care, oral care, wound care and women’s healthcare fields, as well as nutritional and over-the-counter pharmaceutical products. Major brands include AVEENO skin care products; BAND-AID Brand Adhesive Bandages; CAREFREE Pantiliners; CLEAN & CLEAR teen skin care products; JOHNSON’S Baby and Adult lines of products; MOTRIN IB ibuprofen products; NEUTROGENA skin and hair care products; RoC skin care products; PEPCID AC Acid Controller from Johnson & Johnson and Merck Consumer Pharmaceuticals Co.; REMBRANDT brand of oral care products; SPLENDA No Calorie Sweetener; STAYFREE sanitary protection products, and the family of TYLENOL acetaminophen products. These products are marketed principally to the general public and sold both to wholesalers and directly to independent and chain retail outlets throughout the world. The Consumer Healthcare business of Pfizer Inc. comprises products related to self-medications for oral care, upper-respiratory health, tobacco dependence, gastrointestinal health, skin care, eye care and hair growth. Major brands of the Consumer Healthcare business of Pfizer Inc. include LISTERINE oral care products, the NICORETTE line of smoking cessation treatments, and SUDAFED cold, flu and allergy products.

Pharmaceutical

The Pharmaceutical segment includes products in the therapeutic areas, such as anti-fungal, anti-infective, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, psychotropic (central nervous system), urology and virology. These products are distributed directly to retailers, wholesalers and healthcare professionals for prescription use by the general public. Key products in the Pharmaceutical segment include RISPERDAL (risperidone) and RISPERDAL CONSTA (risperidone long-acting injection), for treatment of the symptoms of schizophrenia; PROCRIT (Epoetin alfa, sold outside the United States as EPREX), a biotechnology-derived product that stimulates red blood cell production; REMICADE (infliximab), a monoclonal antibody therapy indicated to treat the symptoms of Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, chronic severe plaque psoriasis and use in the treatment of rheumatoid arthritis; TOPAMAX (topiramate), an anti-epileptic and migraine prevention treatment; LEVAQUIN (levofloxacin) and FLOXIN (ofloxacin), both in the anti-infective field; DURAGESIC/Fentanyl Transdermal (fentanyl transdermal system, sold outside the United States as DUROGESIC), a treatment for chronic pain that offers a delivery system; ORTHO EVRA (norelgestromin/ethinyl estradiol transdermal system), a contraceptive patch approved by the United States Food and Drug Administration (FDA) and ORTHO TRI-CYCLEN LO (norgestimate/ethinyl estradiol), a low dose oral contraceptive; CONCERTA (methylphenidate HCl) a product for the treatment of attention deficit hyperactivity disorder, and NATRECOR (nesiritide), a product for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.

Medical Devices and Diagnostics

The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. These products include Cordis’ circulatory disease management products; DePuy’s orthopaedic joint reconstruction and spinal care products; Ethicon’s wound care and women’s health products; Ethicon Endo-Surgery’s minimally invasive surgical products; LifeScan’s blood glucose monitoring and insulin delivery products; Ortho-Clinical Diagnostics’ professional diagnostic products, and Vision Care’s disposable contact lenses. Distribution to these health care professional markets is done both directly and through surgical supply and other dealers.